骨髓增生异常综合征：乘浪前行。
Myelodysplastic Syndrome: Riding the Crest of the Wave.
作者信息
Ramos Fernando
机构信息
Department of Hematology, Hospital Universitario de León, Altos de Nava s/n, E-24071 León, Spain.
出版信息
J Clin Med. 2022 Mar 14;11(6):1606. doi: 10.3390/jcm11061606.
Abstract
Myelodysplastic syndrome (MDS) is a group of clonal disorders that arise in pluripotent bone marrow stem cells and present with characteristic phenotypical features (both morphological and flow cytometrical), as well as genotypical abnormalities [...].
摘要
骨髓增生异常综合征（MDS）是一组起源于多能骨髓干细胞的克隆性疾病，具有特征性的表型特征（包括形态学和流式细胞术特征）以及基因型异常[...]。
相似文献
1
Myelodysplastic Syndrome: Riding the Crest of the Wave.骨髓增生异常综合征：乘浪前行。
J Clin Med. 2022 Mar 14;11(6):1606. doi: 10.3390/jcm11061606.
2
Physician Education: Myelodysplastic Syndrome.医师教育：骨髓增生异常综合征
Oncologist. 1996;1(4):284-287.
3
Recurrent Abnormal Clones in Myelodysplastic Syndrome Marrow Originate from Cells at a Pluripotent Stem Level and Maintain Their Early Differentiation Potency.骨髓增生异常综合征骨髓中的复发性异常克隆起源于多能干细胞水平的细胞，并维持其早期分化潜能。
Cancer Invest. 2015;33(8):369-77. doi: 10.3109/07357907.2015.1044665. Epub 2015 Jul 2.
4
Special Education: Aplastic Anemia.特殊教育：再生障碍性贫血。
Oncologist. 1996;1(3):187-189.
5
Purification of Bone Marrow Clonal Cells from Patients with Myelodysplastic Syndrome via IGF-IR.通过胰岛素样生长因子1受体（IGF-IR）从骨髓增生异常综合征患者中纯化骨髓克隆细胞
PLoS One. 2015 Oct 15;10(10):e0140372. doi: 10.1371/journal.pone.0140372. eCollection 2015.
6
7
[Study on phenotypic and cytogenetic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes].骨髓增生异常综合征中骨髓间充质干细胞的表型及细胞遗传学特征研究
Zhonghua Xue Ye Xue Za Zhi. 2013 Feb;34(2):127-32.
8
[Diagnosis and treatment of childhood myelodysplastic syndrome].儿童骨髓增生异常综合征的诊断与治疗
Rinsho Ketsueki. 2021;62(4):229-238. doi: 10.11406/rinketsu.62.229.
9
Myelodysplastic syndrome occurring after autologous bone marrow transplantation for lymphoma. Morphologic features.
Am J Clin Pathol. 1997 Oct;108(4):369-77. doi: 10.1093/ajcp/108.4.369.
本文引用的文献
1
Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.供者克隆性造血与移植后受者结局
J Clin Oncol. 2022 Jan 10;40(2):189-201. doi: 10.1200/JCO.21.02286. Epub 2021 Nov 18.
2
Current Therapy of the Patients with MDS: Walking towards Personalized Therapy.骨髓增生异常综合征患者的当前治疗：迈向个性化治疗
J Clin Med. 2021 May 13;10(10):2107. doi: 10.3390/jcm10102107.
3
Prognosis in Myelodysplastic Syndromes: The Clinical Challenge of Genomic Integration.骨髓增生异常综合征的预后：基因组整合的临床挑战
J Clin Med. 2021 May 11;10(10):2052. doi: 10.3390/jcm10102052.
4
VEXAS syndrome.VEXAS 综合征。
Blood. 2021 Jul 1;137(26):3591-3594. doi: 10.1182/blood.2021011455.
5
Difficult Cases of Paroxysmal Nocturnal Hemoglobinuria: Diagnosis and Therapeutic Novelties.阵发性睡眠性血红蛋白尿疑难病例：诊断与治疗新进展
J Clin Med. 2021 Mar 1;10(5):948. doi: 10.3390/jcm10050948.
6
The role of clonal haematopoiesis in cardiovascular diseases: epidemiology and experimental studies.克隆性造血在心血管疾病中的作用：流行病学和实验研究。
J Intern Med. 2020 Nov;288(5):507-517. doi: 10.1111/joim.13130. Epub 2020 Jul 27.
7
Myelodysplastic syndromes: moving towards personalized management.骨髓增生异常综合征：走向个体化治疗。
Haematologica. 2020 Jul;105(7):1765-1779. doi: 10.3324/haematol.2020.248955. Epub 2020 May 21.
8
Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week.克隆性造血：衰老、心血管疾病和癌症的交汇点：JACC 本周综述专题。
J Am Coll Cardiol. 2019 Jul 30;74(4):567-577. doi: 10.1016/j.jacc.2019.06.007.
9
Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group.采用多维评估患者病情和外周血基因突变分析，改善骨髓增生异常综合征患者的预后预测：西班牙 MDS 组的前瞻性研究。
Am J Hematol. 2017 Sep;92(9):E534-E541. doi: 10.1002/ajh.24813. Epub 2017 Jul 19.
Zotero 插件